Stimulation of glucose uptake and improvement of insulin resistance by aromadendrin

Pharmacology

Volumn 88, Issue 5-6, 2011, Pages 266-274

  Zhang, Wei Yun ^a,b   Lee, Jung Jin ^a   Kim, In Su ^a   Kim, Yohan ^a   Myung, Chang Seon ^a  

^a Chungnam National University   (South Korea)

^b XIAMEN UNIVERSITY   (China)

Author keywords

Akt PKB; Aromadendrin; Glucose uptake; Insulin resistance; PPAR 2

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; AROMADENDRIN; FATTY ACID BINDING PROTEIN; FLAVONOID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PLANT EXTRACT; PROTEIN KINASE B; ROSIGLITAZONE; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; DRUG MECHANISM; ENZYME INHIBITION; GLEDITSIA SINENSIS; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INSULIN RESISTANCE; MEDICINAL PLANT; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CELL LINE, TUMOR; FATTY ACID-BINDING PROTEINS; FLAVONOIDS; GLUCOSE; HEPATOCYTES; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MICE; PHOSPHORYLATION; PPAR GAMMA; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER;

EID: 80155189594     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000331862     Document Type: Article

References (39)

1. Pinent M, Blay M, Blade MC, Salvado MJ, Arola L, Ardevol A: Grape seed-derived procyanidins have an antihyperglycemic effect in streptozotocin-induced diabetic rats and insulinomimetic activity in insulin-sensitive cell lines. Endocrinology 2004; 145: 4985-4990. (Pubitemid 39551116)
2. Tontonoz P, Hu E, Spiegelman BM: Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor Curr Opin Genet Dev 1995; 5: 571-576.
3. Adams M, Montague CT, Prins JB, Holder JC, Smith SA, Sanders L, Digby JE, Sewter CP, Lazar MA, Chatterjee VK, O'Rahilly S: Activators of peroxisome proliferator-activated receptor have depot-specific effects on human preadipocyte differentiation. J Clin Invest 1997; 100: 3149-3153. (Pubitemid 28022853)
4. Hamm JK, el Jack AK, Pilch PF, Farmer SR: Role of PPAR in regulating adipocyte differentiation and insulin-responsive glucose uptake. Ann NY Acad Sci 1999; 892: 134-145.
5. Nugent C, Prins JB, Whitehead JP, Wentworth JM, Chatterjee VK, O'Rahilly S: Arachidonic acid stimulates glucose uptake in 3T3-L1 adipocytes by increasing GLUT1 and GLUT4 levels at the plasma membrane: Evidene for involvement of lipoxygenase metabolites and peroxisome proliferator-activated receptor J Biol Chem 2001; 276: 9149-9157.
6. Saltiel AR, Olefsky JM: Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 1996; 45: 1661-1669. (Pubitemid 26398943)
7. Olefsky JM, Saltiel AR: PPAR and glucose homeostasis. Trends Endocrinol Metab 2000; 11: 362-368.
8. Picard F, Auwerx J: PPAR and glucose homeostasis. Annu Rev Nutr 2002; 22: 167-197.
9. Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM: MPPAR 2: Tissue-specific regulator of an adipocyte enhancer. Genes Dev 1994; 8: 1224-1234.
10. Shepherd PR, Withers DJ, Siddle K: Phosphoinositide 3-kinase: The key switch mechanism in insulin signaling. Biochem J 1998; 333: 471-490. (Pubitemid 28398511)
11. Jiang G, Dallas-Yang Q, Biswas S, Li Z, Zhang BB: Rosiglitazone, an agonist of peroxisome- proliferator-activated receptor (PPAR), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo. Biochem J 2004; 377: 339-346. (Pubitemid 38142189)
12. Nakajima K, Yamauchi K, Shigematsu S, Ikeo S, Komatsu M, Aizawa T, Hashizume K: Selective attenuation of metabolic branch of insulin receptor down-signaling by high glucose in a hepatoma cell line, HepG2 cells. J Biol Chem 2000; 275: 20880-20886. (Pubitemid 30457683)
13. Zang M, Zuccollo A, Hou X, Nagata D, Walsh K, Herscovitz H, Brecher P, Ruderman NB, Cohen RA: AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. J Biol Chem 2004; 297: 47898-47905. (Pubitemid 39540941)
14. Tilg H, Moschen AR: Inflammatory mechanism in the regulation of insulin resistance. Mol Med 2008; 14: 222-231. (Pubitemid 351481853)
15. Bonnefont-Rousselot D, Bastard JP, Jaudon MC, Delattre J: Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab 2000; 26: 163-176. (Pubitemid 30435761)
16. Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K, van Leeuwen PA: Flavonoids: A review of probable mechanisms of action and potential applications. Am J Clin Nutr 2001; 74: 418-425. (Pubitemid 32880250)
17. Ahmad F, Khalid P, Khan MM, Rastogi AK, Kidwai JR: Insulin like activity in (-) epicatechin. Acta Diabetol Lat 1989; 26: 291-300. (Pubitemid 20114421)
18. Vessal M, Hemmati M, Vasei M: Antidiabetic effects of quercetin in streptozotocin-induced diabetic rats. Comp Biochem Physiol C Toxicol Pharmacol 2003; 135C:357-364. (Pubitemid 36962949)
19. Zhang X, Hung TM, Phuong PT, Ngoc TM, Min BS, Song KS, Seong YH, Bae K: Antiinflammatory activity of favonoids from polulus davidiana. Arch Pharm Res 2006; 29: 1102-1108.
20. Lee YJ, Kim S, Lee SJ, Ham I, Whang WK: Antioxidant activities of new flavonoids from Cudrania tricuspidata root bark. Arch Pharm Res 2009; 32: 195-200.
21. Saito T, Abe D, Sekiya K: Sakuranetin induces adipogenesis of 3T3-L1 cells through enhanced expression of PPAR 2. Biochem Biophys Res Commun 2008; 372: 835-839.
22. Xu ME, Xiao SZ, Sun YH, Ou-yang Y, Guan C, Zheng XX: A preadipocyte differentiation assay as a method for screening potential anti- type II diabetes drugs from herbal extracts. Planta Med 2006; 72: 14-19. (Pubitemid 43241586)
23. Zou C, Wang Y, Shen Z: 2-NBDG as a fluorescent indicator for direct glucose uptake measurement. J Biochem Biophys Methods 2005; 64: 207-215. (Pubitemid 41393730)
24. Zhang WY, Lee JJ, Kim IS, Kim Y, Park JS, Myung CS: 7- O -methylaromadendrin stimulates glucose uptake and improves insulin resistance in vitro. Biol Pharm Bull 2010; 33: 1494-1499.
25. Zhang WY, Lee JJ, Kim Y, Kim IS, Park JS, Myung CS: Amelioration of insulin resistance by scopoletin in high-glucose-induced, insulin-resistant HepG2 cells. Horm Metab Res 2010; 42: 930-935.
26. Sivitz WI, Lee EC: Assessment of glucose transporter gene expression using the polymerase chain reaction. Endocrinology 1991; 128: 2387-2394.
27. Watson RT, Kanzaki M, Pessin JE: Regulated membrane trafficking of the insulin-responsive glucose transporter 4 in adipocytes. Endocr Rev 2004; 25: 177-204. (Pubitemid 38501393)
28. Gherzi R, Melioli G, de Luca M, D'Agostino A, Distefano G, Guastella M, D'Anna F, Franzi AT, Cancedda R: 'HepG2/erythroid/ brain' type glucose transporter (GLUT1) is highly expressed in human epidermis: Keratinocyte differentiation affects GLUT1 levels in reconstituted epidermis. J Cell Physiol 1992; 150: 463-474.
29. Takanaga H, Chaudhuri B, Frommer WB: GLUT1 and GLUT9 as major contributors to glucose influx in HepG2 cells identified by a high sensitivity intramolecular FRET glucose sensor. Biochim Biophys Acta 2008; 1778: 1091-1099.
30. Spiegelman BM: PPAR-α: Adipogenic regulator and thiazolidinedione receptor. Diabetes 1998; 47: 507-514. (Pubitemid 28160438)
31. Cho MC, Lee K, Paik SG, Yoon DY: Peroxisome proliferator-activated receptor (PPAR) modulators and metabolic disorders. PPAR Res 2008; 2008: 679137.
32. Cornelius P, MacDougald OA, Lane MD: Regulation of adipocyte development. Annu Rev Nutr 1994; 14: 99-129. (Pubitemid 24261832)
33. Nawano M, Ueta K, Oku A, Arakawa K, Saito A, Funaki M, Anai M, Kikuchi M, Oka Y, Asano T: Hyperglycemia impairs the insulin signaling step between PI 3-kinase and Akt/ PKB activations in ZDF rat liver. Biochem Biophys Res Commun 1999; 266: 252-256. (Pubitemid 30028800)
34. Cusi K, Maezono K, Osman A, Pendergrass M, Patti ME, Pratipanawatr T, DeFronzo RA, Kahn CR, Mandarino LJ: Insulin resistance differentially affects the PI 3-kinaseand MAP kinase-mediated signaling in human muscle. J Clin Invest 2000; 105: 311-320. (Pubitemid 30094451)
35. Coffer PJ, Jin J, Woodgett JR: Protein kinase B (c-Akt): A multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem J 1998; 335: 1-13. (Pubitemid 28477043)
36. Cheatham B, Vlahos CJ, Cheatham L, Wang L, Blenis J, Kahn CR: Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol 1994; 14: 4902-4911. (Pubitemid 24196839)
37. Quon MJ, Chen H, Ing BL, Liu ML, Zarnowsk MJ, Yonezawa K, Kasuga M, Cushman SW, Taylor SI: Roles of 1-phosphatidylinositol 3-kinase and ras in regulating translocation of GLUT4 in transfected rat adipose cells. Mol Cell Biol 1995; 15: 5403-5411.
38. Kohn AD, Summers SA, Birnbaum MJ, Roth RA: Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 1996; 271: 31372-31378. (Pubitemid 26408588)
39. Magun R, Burgering BM, Coffer PJ, Pardasani D, Lin Y, Chabot J, Sorisky A: Expression of a constitutively activated form of protein kinase B (c-Akt) in 3T3-L1 preadipose cells causes spontaneous differentiation. Endocrinology 1996; 137: 3590-3593. (Pubitemid 26250216)